Chemoradiotherapy for Head and Neck Cancer
Author:
Affiliation:
1. Department of Precision Medicine, University of Campania “L. Vanvitelli”, 80138 Naples, Italy
2. Radiotherapy Unit, Ospedale del Mare, ASL Napoli 1 Centro, 80138 Naples, Italy
Abstract
Publisher
MDPI AG
Subject
Cancer Research,Oncology
Link
https://www.mdpi.com/2072-6694/15/10/2820/pdf
Reference7 articles.
1. D’Urso, P., Farneti, A., Marucci, L., Marzi, S., Piludu, F., Vidiri, A., and Sanguineti, G. (2022). Predictors of Outcome after (Chemo)Radiotherapy for Node-Positive Oropharyngeal Cancer: The Role of Functional MRI. Cancers, 14.
2. Callejas-Valera, J.L., Vermeer, D.W., Lucido, C.T., Williamson, C., Killian, M., Vermeer, P.D., Spanos, W.C., and Powell, S.F. (2022). Characterization of the Immune Response to PD-1 Blockade during Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma. Cancers, 14.
3. Islam, K.A., Chow, L.K.-Y., Kam, N.W., Wang, Y., Chiang, C.L., Choi, H.C.-W., Xia, Y.-F., Lee, A.W.-M., Ng, W.T., and Dai, W. (2022). Prognostic Biomarkers for Survival in Nasopharyngeal Carcinoma: A Systematic Review of the Literature. Cancers, 14.
4. Tuček, L., Vošmik, M., and Petera, J. (2022). Is There Still a Place for Brachytherapy in the Modern Treatment of Early-Stage Oral Cancer?. Cancers, 14.
5. Butkiewicz, D., Gdowicz-Kłosok, A., Krześniak, M., Rutkowski, T., Łasut-Szyszka, B., and Składowski, K. (2022). Germline Variants in Angiogenesis-Related Genes Contribute to Clinical Outcome in Head and Neck Squamous Cell Carcinoma. Cancers, 14.
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A novel prognostic score (HAMP) for head and neck cancer patients with single and multiple SBRT‐treated lung metastases derived from retrospective analyses of survival outcome;Head & Neck;2024-08-08
2. PRINCIPLES OF SPECIFIC TREATMENT AND PALLIATIVE CARE IN ADVANCED HEAD AND NECK CANCER;ROM J ORAL REHABIL;2024
3. Expression of 3q Oncogene SEC62 Predicts Survival in Head and Neck Squamous Cell Carcinoma Patients Treated with Primary Chemoradiation;Cancers;2023-12-24
4. Survival, Treatment Outcome, and Safety of Multiple and Repeated Courses of Stereotactic Body Radiotherapy for Pulmonary Oligometastases of Head and Neck Squamous Cell Carcinoma;Cancers;2023-11-01
5. New Propargyloxy Derivatives of Galangin, Kaempferol and Fisetin—Synthesis, Spectroscopic Analysis and In Vitro Anticancer Activity on Head and Neck Cancer Cells;Cells;2023-09-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3